A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

Inclusion Criteria: * Have a diagnosis of schizophrenia * Are currently taking olanzapine, risperidone, paliperidone, or quetiapine and have gained weight from treatment while on these medications * Must be on a stable dose of medication for 1 month prior to Screening * Have a BMI ≥30 kg/m\^2. Exclusion Criteria: * Have a history of a medical condition affecting body weight (eg, poorly controlled hyper- or hypothyroidism; eating disorder such as anorexia, bulimia, or binge eating; or polycystic ovary syndrome) * Have poorly controlled diabetes mellitus * Have poorly controlled hypertension * Have a history of symptomatic hypotension * Have a history of orthostatic hypotension * Have a history of a seizure disorder.